Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Innovate Alabama
Deal Size : $0.1 million
Deal Type : Funding
Endomimetics Wins $100K Grant to Develop Bionanomatrix for Knee Arthroplasty Complications
Details : The funding aims to support research to develop and evaluate the potential of a Bionanomatrix formulation to reduce infectious and inflammatory complications that occur following knee replacement.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 07, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Innovate Alabama
Deal Size : $0.1 million
Deal Type : Funding